nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP4F2—renal system—cervical cancer	0.0336	0.0446	CbGeAlD
Fingolimod—CYP4F2—mammalian vulva—cervical cancer	0.0314	0.0417	CbGeAlD
Fingolimod—S1PR3—decidua—cervical cancer	0.0304	0.0403	CbGeAlD
Fingolimod—S1PR5—female reproductive system—cervical cancer	0.0287	0.0381	CbGeAlD
Fingolimod—S1PR1—epithelium—cervical cancer	0.0283	0.0376	CbGeAlD
Fingolimod—CYP4F12—Tryptophan metabolism—UBE3A—cervical cancer	0.0278	0.113	CbGpPWpGaD
Fingolimod—S1PR1—decidua—cervical cancer	0.0268	0.0355	CbGeAlD
Fingolimod—CYP4F12—uterine cervix—cervical cancer	0.0267	0.0354	CbGeAlD
Fingolimod—SPHK1—decidua—cervical cancer	0.0265	0.0351	CbGeAlD
Fingolimod—SPHK1—renal system—cervical cancer	0.026	0.0345	CbGeAlD
Fingolimod—SPHK1—endometrium—cervical cancer	0.0251	0.0334	CbGeAlD
Fingolimod—CYP4F2—vagina—cervical cancer	0.0244	0.0323	CbGeAlD
Fingolimod—SPHK1—mammalian vulva—cervical cancer	0.0243	0.0323	CbGeAlD
Fingolimod—CYP4F12—endometrium—cervical cancer	0.0242	0.032	CbGeAlD
Fingolimod—S1PR3—female reproductive system—cervical cancer	0.0239	0.0317	CbGeAlD
Fingolimod—CYP4F12—mammalian vulva—cervical cancer	0.0234	0.031	CbGeAlD
Fingolimod—SPHK1—uterus—cervical cancer	0.0232	0.0307	CbGeAlD
Fingolimod—CYP4F12—uterus—cervical cancer	0.0223	0.0295	CbGeAlD
Fingolimod—S1PR3—female gonad—cervical cancer	0.0217	0.0288	CbGeAlD
Fingolimod—S1PR1—female reproductive system—cervical cancer	0.0211	0.0279	CbGeAlD
Fingolimod—SPHK1—female reproductive system—cervical cancer	0.0208	0.0276	CbGeAlD
Fingolimod—CYP4F12—female reproductive system—cervical cancer	0.02	0.0265	CbGeAlD
Fingolimod—S1PR4—lymph node—cervical cancer	0.02	0.0265	CbGeAlD
Fingolimod—S1PR1—female gonad—cervical cancer	0.0192	0.0254	CbGeAlD
Fingolimod—S1PR1—vagina—cervical cancer	0.019	0.0253	CbGeAlD
Fingolimod—SPHK1—female gonad—cervical cancer	0.019	0.0251	CbGeAlD
Fingolimod—SPHK1—vagina—cervical cancer	0.0188	0.025	CbGeAlD
Fingolimod—CYP4F12—female gonad—cervical cancer	0.0182	0.0242	CbGeAlD
Fingolimod—CYP4F12—vagina—cervical cancer	0.0181	0.024	CbGeAlD
Fingolimod—S1PR5—lymph node—cervical cancer	0.0168	0.0223	CbGeAlD
Fingolimod—S1PR3—lymph node—cervical cancer	0.014	0.0185	CbGeAlD
Fingolimod—S1PR1—lymph node—cervical cancer	0.0123	0.0163	CbGeAlD
Fingolimod—SPHK1—lymph node—cervical cancer	0.0122	0.0162	CbGeAlD
Fingolimod—CYP4F12—lymph node—cervical cancer	0.0117	0.0155	CbGeAlD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00748	0.0304	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0072	0.0293	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0072	0.0293	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00654	0.0266	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—TAAR6—cervical cancer	0.0057	0.0232	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—TAAR6—cervical cancer	0.00548	0.0223	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—TAAR6—cervical cancer	0.00548	0.0223	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—TAAR6—cervical cancer	0.00498	0.0202	CbGpPWpGaD
Fingolimod—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—cervical cancer	0.00486	0.0198	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—WNT2—cervical cancer	0.00445	0.0181	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—WNT2—cervical cancer	0.00428	0.0174	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—WNT2—cervical cancer	0.00428	0.0174	CbGpPWpGaD
Fingolimod—CYP2E1—renal system—cervical cancer	0.00421	0.00559	CbGeAlD
Fingolimod—S1PR1—GPCR ligand binding—WNT2—cervical cancer	0.00389	0.0158	CbGpPWpGaD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00352	0.0143	CbGpPWpGaD
Fingolimod—CYP3A4—renal system—cervical cancer	0.00339	0.0045	CbGeAlD
Fingolimod—CYP2E1—Tryptophan metabolism—UBE3A—cervical cancer	0.00339	0.0138	CbGpPWpGaD
Fingolimod—CYP2E1—female reproductive system—cervical cancer	0.00337	0.00448	CbGeAlD
Fingolimod—S1PR4—GPCR ligand binding—WNT5A—cervical cancer	0.00337	0.0137	CbGpPWpGaD
Fingolimod—CYP2D6—renal system—cervical cancer	0.00334	0.00443	CbGeAlD
Fingolimod—S1PR3—GPCR ligand binding—WNT5A—cervical cancer	0.00324	0.0132	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—WNT5A—cervical cancer	0.00324	0.0132	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—TAAR6—cervical cancer	0.00322	0.0131	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—TAAR6—cervical cancer	0.0031	0.0126	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—TAAR6—cervical cancer	0.0031	0.0126	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—WNT5A—cervical cancer	0.00295	0.012	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—TAAR6—cervical cancer	0.00292	0.0119	CbGpPWpGaD
Fingolimod—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00291	0.0118	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—TAAR6—cervical cancer	0.00281	0.0114	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—TAAR6—cervical cancer	0.00281	0.0114	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—TAAR6—cervical cancer	0.00281	0.0114	CbGpPWpGaD
Fingolimod—CYP3A4—female reproductive system—cervical cancer	0.00272	0.0036	CbGeAlD
Fingolimod—CYP2D6—female reproductive system—cervical cancer	0.00267	0.00354	CbGeAlD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—MTOR—cervical cancer	0.00263	0.0107	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—TAAR6—cervical cancer	0.00256	0.0104	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—MTOR—cervical cancer	0.00248	0.0101	CbGpPWpGaD
Fingolimod—CYP2D6—female gonad—cervical cancer	0.00243	0.00323	CbGeAlD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—CTNNB1—cervical cancer	0.00233	0.00948	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—WNT2—cervical cancer	0.00228	0.00928	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AKAP13—cervical cancer	0.00221	0.00897	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—CTNNB1—cervical cancer	0.0022	0.00895	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—WNT2—cervical cancer	0.0022	0.00893	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—WNT2—cervical cancer	0.0022	0.00893	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AKAP13—cervical cancer	0.00212	0.00863	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AKAP13—cervical cancer	0.00212	0.00863	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—STAT3—cervical cancer	0.00203	0.00824	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AKAP13—cervical cancer	0.002	0.00814	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—WNT2—cervical cancer	0.002	0.00811	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AKAP13—cervical cancer	0.00193	0.00784	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AKAP13—cervical cancer	0.00193	0.00784	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AKAP13—cervical cancer	0.00193	0.00784	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—STAT3—cervical cancer	0.0018	0.0073	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKAP13—cervical cancer	0.00175	0.00712	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—WNT5A—cervical cancer	0.00173	0.00703	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TAAR6—cervical cancer	0.00173	0.00702	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—WNT5A—cervical cancer	0.00167	0.00677	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—WNT5A—cervical cancer	0.00167	0.00677	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TAAR6—cervical cancer	0.00166	0.00676	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TAAR6—cervical cancer	0.00166	0.00676	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00163	0.00663	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CA9—cervical cancer	0.00159	0.00645	CbGpPWpGaD
Fingolimod—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.00157	0.00639	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—WNT5A—cervical cancer	0.00151	0.00614	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TAAR6—cervical cancer	0.00151	0.00613	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CA9—cervical cancer	0.00137	0.00557	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—WNT2—cervical cancer	0.00135	0.00548	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TAAR6—cervical cancer	0.00134	0.00543	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—WNT2—cervical cancer	0.0013	0.00527	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—WNT2—cervical cancer	0.0013	0.00527	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKAP13—cervical cancer	0.00118	0.00481	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—WNT2—cervical cancer	0.00118	0.00479	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CA9—cervical cancer	0.00118	0.00479	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKAP13—cervical cancer	0.00114	0.00463	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKAP13—cervical cancer	0.00114	0.00463	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—WNT2—cervical cancer	0.00104	0.00424	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKAP13—cervical cancer	0.00103	0.0042	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—WNT5A—cervical cancer	0.00102	0.00415	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—WNT5A—cervical cancer	0.000984	0.004	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—WNT5A—cervical cancer	0.000984	0.004	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKAP13—cervical cancer	0.000916	0.00372	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—WNT5A—cervical cancer	0.000893	0.00363	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—WNT5A—cervical cancer	0.00079	0.00321	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NOTCH2—cervical cancer	0.000717	0.00291	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NOTCH2—cervical cancer	0.00069	0.00281	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NOTCH2—cervical cancer	0.00069	0.00281	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—MTHFR—cervical cancer	0.000645	0.00262	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOTCH2—cervical cancer	0.000627	0.00255	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HES1—cervical cancer	0.000588	0.00239	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HES1—cervical cancer	0.000566	0.0023	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HES1—cervical cancer	0.000566	0.0023	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—MTHFR—cervical cancer	0.000556	0.00226	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOTCH2—cervical cancer	0.000555	0.00225	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CTNNB1—cervical cancer	0.000529	0.00215	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TERT—cervical cancer	0.000515	0.00209	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HES1—cervical cancer	0.000514	0.00209	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TERT—cervical cancer	0.000496	0.00202	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TERT—cervical cancer	0.000496	0.00202	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—MTHFR—cervical cancer	0.000478	0.00194	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—FGFR3—cervical cancer	0.000473	0.00192	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—FGFR3—cervical cancer	0.000455	0.00185	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—FGFR3—cervical cancer	0.000455	0.00185	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HES1—cervical cancer	0.000455	0.00185	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TERT—cervical cancer	0.00045	0.00183	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NOTCH1—cervical cancer	0.000444	0.0018	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NOTCH1—cervical cancer	0.000427	0.00174	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NOTCH1—cervical cancer	0.000427	0.00174	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—FGFR3—cervical cancer	0.000413	0.00168	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TERT—cervical cancer	0.000399	0.00162	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—cervical cancer	0.000396	0.00161	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOTCH1—cervical cancer	0.000388	0.00158	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—cervical cancer	0.000381	0.00155	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—cervical cancer	0.000381	0.00155	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FGFR3—cervical cancer	0.000366	0.00149	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—cervical cancer	0.000346	0.0014	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOTCH1—cervical cancer	0.000343	0.0014	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MTOR—cervical cancer	0.000333	0.00135	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MTOR—cervical cancer	0.00032	0.0013	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MTOR—cervical cancer	0.00032	0.0013	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CASP3—cervical cancer	0.000306	0.00124	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—cervical cancer	0.000295	0.0012	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CASP3—cervical cancer	0.000295	0.0012	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CASP3—cervical cancer	0.000295	0.0012	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MTOR—cervical cancer	0.000291	0.00118	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—cervical cancer	0.000284	0.00115	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—cervical cancer	0.000284	0.00115	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CASP3—cervical cancer	0.000267	0.00109	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—cervical cancer	0.000258	0.00105	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MTOR—cervical cancer	0.000257	0.00105	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—cervical cancer	0.000257	0.00104	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—cervical cancer	0.000247	0.00101	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—cervical cancer	0.000247	0.00101	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP3—cervical cancer	0.000237	0.000962	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—cervical cancer	0.000234	0.000949	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—cervical cancer	0.000228	0.000927	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—cervical cancer	0.000225	0.000914	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—cervical cancer	0.000225	0.000914	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—cervical cancer	0.000225	0.000913	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—cervical cancer	0.000204	0.00083	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—cervical cancer	0.000199	0.000808	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—cervical cancer	0.000196	0.000797	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA9—cervical cancer	0.000193	0.000786	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—cervical cancer	0.000189	0.000767	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—cervical cancer	0.000189	0.000767	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—cervical cancer	0.000181	0.000734	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—cervical cancer	0.000171	0.000697	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—cervical cancer	0.000152	0.000617	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA9—cervical cancer	0.000137	0.000558	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA9—cervical cancer	8.97e-05	0.000365	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—cervical cancer	7.85e-05	0.000319	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—cervical cancer	5.57e-05	0.000226	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—cervical cancer	3.64e-05	0.000148	CbGpPWpGaD
